Skin Cancer

We asked oncology experts what questions patients should ask their doctors soon after receiving a cancer diagnosis. This is their advice.

Researchers have found that among patients with certain melanoma, presurgical targeted therapy and immunotherapy can result in better pathologic response.

Citing toxicities and lack of efficacy, some are calling for caution when treating older patients with melanoma with immune checkpoint inhibitors.

From Teddi Mellencamp revealing that she had more melanoma spots removed to Isabella Strahan announcing being cancer-free, here’s what’s happening in the oncology space this week.

The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.

Perioperative treatment with BRAF and MEK inhibitors was found to benefit some patients with stage 3 and 4 melanoma, according to a recent study.

From the lead singer of Heart’s cancer diagnosis and postponing their tour to Dick Vitale’s upcoming cancer surgery, here’s what’s going on in the cancer space this week.

Following promising European trial results, a new peptide vaccine for melanoma is being studied in America, with results expected next year.

From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.

Are cancer vaccines the new frontier in oncology? Experts and patients weigh in from the front lines.

From Kate Middleton giving an update on her cancer treatment to Kevin Jonas’ skin cancer surgery, here’s what’s happening in the oncology space this week.

Learning that I had cancer — melanoma and renal cell carcinoma — made me feel like I lost something, but I keep looking ahead.

Opdivo plus Yervoy in the neoadjuvant setting reduced the risk for recurrence, progression or death, potentially offering patients with stage 3 melanoma a new standard of care.

Eight-year follow-up showed that Tafinlar plus Mekinist continued to improve outcomes for patients with stage 3 melanoma.

The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.

When my wife was diagnosed with stage 3B melanoma, we decided to openly speak about our fears.

An expert explained the importance of patient choice in treatment decisions for high-risk, resectable melanoma, based on their own treatment goals.

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

An expert explains how gene-expression profile testing can inform treatment decisions for patients with squamous cell carcinoma.

My plastic surgeon helped me accept my new face after basal cell carcinoma left a hole in my face.

A vaccine developer discusses a cancer vaccine that has been shown to potentially boost long-term overall postsurgical survival.

Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.

From Fortnight player, “Ninja” announcing his melanoma diagnosis to an LSU quarterback sporting the name of his teammate with brain cancer, here’s what’s going on in the oncology space this week.

Even the difficult experiences that we share, like the emotional and physical discomfort that comes with a cancer scan, can be a little easier when we know someone else has been through them, too.

From Richard Simmons discussing his skin cancer to Nicole Eggert shaving her head, here’s what’s happening in the oncology space this week.

Patients who underwent breast cancer radiation had higher rates of skin cancer, although altering their treatment plan is unnecessary, an expert said.

From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.

From Jason Kelce honoring the team trainer who has been diagnosed with cancer to deaths in the sports reporting and music world, here’s what’s happening in the oncology space this week.

The Food and Drug Administration approved Amtagvi, a TIL therapy, for patients with advanced melanoma whose disease progressed on or after a checkpoint inhibitor and targeted therapy.

From the San Francisco 49ers’ Trent Williams looking back on his cancer experience to a Republican congressman returning to work after myeloma treatment, here’s what’s happening in the oncology space this week.